Latozinemab | MedChemExpress (MCE)
Latozinemab (AL001) is a recombinant humanized anti-Sortilin monoclonal antibody. Latozinemab effectively binds Sortilin with a high affinity and blocks the interaction between progranulin protein (PGRN) and Sortilin receptor. Latozinemab has the potential for progranulin gene (GRN) mutations causative of Frontotemporal dementia (FTD) (FTD-GRN) research[1][2].
Trivial name | Latozinemab |
Catalog Number | HY-P99688 |
Alternative Name(s) | AL001 |
Research Area | Cancer |
Purity | ≥98.00% |
SMILES | [Latozinemab] |
Size | 1 mg |
Supplier Page | https://www.medchemexpress.com/latozinemab.html |